Published in Nucleic Acids Res on November 25, 1991
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A (1996) 5.93
Modelling Myc inhibition as a cancer therapy. Nature (2008) 5.81
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71
Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89
Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A (1992) 2.72
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
The lac operator-repressor system is functional in the mouse. Genes Dev (2001) 2.24
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol (1998) 2.23
Endogenous Myc maintains the tumor microenvironment. Genes Dev (2011) 2.16
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09
Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep (2004) 1.99
Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.92
DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol (1995) 1.83
Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol (2000) 1.78
In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci U S A (1993) 1.43
CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol (2005) 1.37
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol (1998) 1.34
Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol (1995) 1.27
Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res (1996) 1.25
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS One (2009) 1.16
Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases. BMC Biotechnol (2006) 1.12
High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum Gene Ther (2007) 1.05
Ubiquitous and uniform in vivo fluorescence in ROSA26-EGFP BAC transgenic mice. Genesis (2007) 0.98
An opportunistic promoter sharing regulatory sequences with either a muscle-specific or a ubiquitous promoter in the human aldolase A gene. Mol Cell Biol (1993) 0.87
Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice. Am J Pathol (1999) 0.86
Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo. J Virol (2001) 0.83
Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging. Mol Imaging Biol (2011) 0.82
Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J Biol Chem (2013) 0.81
Transgenic mouse with the herpes simplex virus type 1 latency-associated gene: expression and function of the transgene. J Virol (2003) 0.80
Production of transgenic pigs mediated by pseudotyped lentivirus and sperm. PLoS One (2012) 0.79
Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscle. BMC Genet (2000) 0.79
A comparative analysis of constitutive promoters located in adeno-associated viral vectors. PLoS One (2014) 0.78
Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells. Genet Vaccines Ther (2004) 0.76
Zinc finger protein 407 overexpression upregulates PPAR target gene expression and improves glucose homeostasis in mice. Am J Physiol Endocrinol Metab (2016) 0.75
Characterization of the Promoter Regions of Two Sheep Keratin-Associated Protein Genes for Hair Cortex-Specific Expression. PLoS One (2016) 0.75
pTOM, a vector for expressing two proteins in mammalian cells. Anal Biochem (2009) 0.75
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Germ-line transformation of mice. Annu Rev Genet (1986) 8.67
Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol (1985) 5.47
Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene (1986) 3.01
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol (1990) 2.80
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol (1990) 2.06
Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences. Science (1986) 1.64
Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol (1988) 1.47
Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. Proc Natl Acad Sci U S A (1989) 1.46
The palindromic series I repeats in the simian cytomegalovirus major immediate-early promoter behave as both strong basal enhancers and cyclic AMP response elements. J Virol (1990) 1.45
The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer. J Gen Virol (1989) 1.39
Neural regulation of gene expression by an acetylcholine receptor promoter in muscle of transgenic mice. Neuron (1989) 1.28
Efficient transfection and expression of heterologous genes in PC12 cells. DNA Cell Biol (1990) 1.23
The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice. AIDS Res Hum Retroviruses (1989) 1.17
Provision of the immunoglobulin heavy chain enhancer downstream of a test gene is sufficient to confer lymphoid-specific expression in transgenic mice. Eur J Immunol (1987) 1.15
Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP. J Virol (1990) 1.05
Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer. Nucleic Acids Res (1991) 1.03
Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp Hematol (1990) 1.00
Expression and amplification in transgenic mice of a polyoma virus mutant regulatory region. Nucleic Acids Res (1988) 0.95
Cryptic human growth hormone gene sequences direct gonadotroph-specific expression in transgenic mice. Mol Endocrinol (1989) 0.89
Tissue-specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells. Hepatology (1989) 0.87
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet (1999) 8.17
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71
Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell (1984) 5.61
Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63
Longevity and Medicare expenditures. N Engl J Med (1995) 3.51
Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res (2001) 3.45
Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol (1999) 3.04
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci U S A (1995) 2.79
Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J (1986) 2.62
Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol (1989) 2.52
Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development (1995) 2.50
Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med (1997) 2.49
The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev (1998) 2.25
Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.23
A population-based, multivariate analysis of the association between 911 access and per-capita county trauma death rates. Ann Emerg Med (1992) 2.19
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther (1999) 2.17
Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development (2000) 2.10
Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med (1999) 2.07
Interaction of protein with DNA in vitro. Methods Enzymol (1987) 2.07
Women in UK cardiology: report of a Working Group of the British Cardiac Society. Heart (2005) 2.06
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity (1997) 2.01
High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature (1985) 2.00
Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron (1996) 1.98
Development of an activities of daily living scale to screen for dementia in an illiterate rural older population in India. Age Ageing (1999) 1.93
Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.92
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
Transgenic factor VIII: the milky way and beyond. Nat Biotechnol (1997) 1.88
Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol (1996) 1.86
Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J (1993) 1.86
Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. J Biol Chem (1991) 1.84
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82
Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80
Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene. J Virol (1988) 1.78
Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol (2000) 1.76
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics (1997) 1.70
Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol (2001) 1.66
Alteration of monocyte function following major injury. Arch Surg (1988) 1.64
Plasma-catecholamines after cardiac infarction. Lancet (1969) 1.64
Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol (1996) 1.62
Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol Endocrinol (1988) 1.59
Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol (1996) 1.59
The North Carolina Black Churches United for Better Health Project: intervention and process evaluation. Health Educ Behav (2000) 1.57
Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol (1995) 1.56
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. J Clin Microbiol (1991) 1.55
Prevalence of isolated urethral asymptomatic Chlamydia trachomatis infection in the absence of cervical infection in incarcerated adolescent girls. Sex Transm Dis (1993) 1.55
Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U S A (1994) 1.53
STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood (1997) 1.53
A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci U S A (1988) 1.49
An outbreak of Norwalk gastroenteritis associated with swimming in a pool and secondary person-to-person transmission. Am J Epidemiol (1982) 1.47
Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol (1988) 1.47
Head CT scanning versus urgent exploration in the hypotensive blunt trauma patient. J Trauma (1993) 1.43
Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol (2000) 1.42
Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. Mech Dev (2001) 1.40
You and your hearing-impaired patient. N Y State Dent J (2001) 1.39
Work-related injuries. Med J Aust (1989) 1.39
Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ (1999) 1.38
Comparison of transportation media for the culturing of N. gonorrhoeae. Am J Clin Pathol (1974) 1.38
Nuclear proteins from lactating mammary glands bind to the promoter of a milk protein gene. Nucleic Acids Res (1987) 1.37
Combined epidural/general anaesthesia. Can J Anaesth (1997) 1.34
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33
Solution structure of the sodium channel inactivation gate. Biochemistry (1999) 1.31
Sensory-affective relationships among different types of clinical and experimental pain. Pain (1987) 1.31
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin. J Antibiot (Tokyo) (1979) 1.30
The microarray explorer tool for data mining of cDNA microarrays: application for the mammary gland. Nucleic Acids Res (2000) 1.30
Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development. Development (1999) 1.25
Asymptomatic Chlamydia trachomatis infections in teenage males. J Adolesc Health Care (1988) 1.25
Sensory processing of water currents by fishes. Philos Trans R Soc Lond B Biol Sci (2000) 1.23
Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene (1998) 1.22
Sexual communication is associated with condom use by sexually active incarcerated adolescents. J Adolesc Health (1994) 1.21
Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J Virol (1990) 1.21
Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J Biol Chem (1999) 1.20
Risk factors for candidemia in a children's hospital. Clin Infect Dis (1998) 1.20
Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech Dev (1996) 1.20
Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev Biol (1997) 1.19
The spectrum of abdominal injuries associated with the use of seat belts. J Trauma (1991) 1.19
Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol Cell Biol (1989) 1.19
Syntactic determinants of sentence comprehension in aphasia. Cognition (1985) 1.18
Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group. J Infect Dis (1994) 1.18
Oxytocin and milk removal are required for post-partum mammary-gland development. Genes Funct (1997) 1.17
A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther (1999) 1.16
Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol (2004) 1.16
Antisense oligodeoxyribonucleotide-directed cleavage of maternal mRNA in Xenopus oocytes and embryos. Gene (1988) 1.15
Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity (1996) 1.13
Effect of radiation therapy on the latest generation of pacemakers and implantable cardioverter defibrillators: A systematic review. J Med Imaging Radiat Oncol (2010) 1.13
Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development (1997) 1.12
High affinity binding of pyrethroids to the alpha subunit of brain sodium channels. Mol Pharmacol (1997) 1.12
Cloning and characterization of a second human NRAMP gene on chromosome 12q13. Mamm Genome (1995) 1.12
Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth Differ (1998) 1.12
The Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue. Genomics (2001) 1.12
Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ (1996) 1.11
Side-branching in the mammary gland: the progesterone-Wnt connection. Genes Dev (2000) 1.09
Regulation of mammary differentiation by extracellular matrix involves protein-tyrosine phosphatases. J Biol Chem (1998) 1.07
Standard setting in paediatrics. Nursing (Lond) (1990) 1.07